Integrated results from the COPERNICUS and GALILEO studies.

about

Integrated results from the COPERNICUS and GALILEO studies.

Item

http://www.wikidata.org/entity/Q41546137

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Integrated results from the COPERNICUS and GALILEO studies.

@en

type

Item

label

Integrated results from the COPERNICUS and GALILEO studies.

@en

prefLabel

Integrated results from the COPERNICUS and GALILEO studies.

@en

P1476

Integrated results from the COPERNICUS and GALILEO studies.

@en

P2093

Amelie Pielen

http://www.w3.org/2001/XMLSchema#string

Brigitte Stemper

http://www.w3.org/2001/XMLSchema#string

Christiane Ahlers

http://www.w3.org/2001/XMLSchema#string

David S Boyer

http://www.w3.org/2001/XMLSchema#string

Friedrich Asmus

http://www.w3.org/2001/XMLSchema#string

Jean-Francois Korobelnik

http://www.w3.org/2001/XMLSchema#string

Julia A Haller

http://www.w3.org/2001/XMLSchema#string

Kay D Rittenhouse

http://www.w3.org/2001/XMLSchema#string

Namrata Saroj

http://www.w3.org/2001/XMLSchema#string

Oliver Zeitz

http://www.w3.org/2001/XMLSchema#string

P2860

The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia

Clinical practice. Retinal-vein occlusion.

The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study

Efficacy and safety of intravitreal therapy in macular edema due to branch and central retinal vein occlusion: a systematic review.

RETINAL VEIN OCCLUSIONS, FROM BASICS TO THE LATEST TREATMENT.

Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab

Capacity of aflibercept to counteract VEGF-stimulated abnormal behavior of retinal microvascular endothelial cells.

Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study.

Intravitreal Aflibercept Injection for Macular Edema Resulting from Central Retinal Vein Occlusion: One-Year Results of the Phase 3 GALILEO Study.

Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant.

P304

1533-1540

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OPTH.S140665

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Frank G Holz

P577

2017-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28883712

http://www.w3.org/2001/XMLSchema#string

P932

5574701

http://www.w3.org/2001/XMLSchema#string